These results follow similar findings from the companys ATTAIN-1 trial released earlier this month, which tested the drug on people who were overweight or obese without type 2 diabetes (in general, people without diabetes tend to lose more weight from GLP-1 therapy than those with diabetes)
Medical News Today spoke to three medical experts Hector Perez, MD, a board-certified bariatric surgeon at Renew Bariatrics and an advisor at BestSurgeons, Mir Ali, MD, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, and David Cutler, MD, a board-certified family medicine physician at Providence Saint Johns Health Center in Santa Monica, CA about weight loss injections, their side effects, and how to spot signs of acute pancreatitis
Baldini E, Tincani GP
The conjugation of myristic acid results half-life extension from 4-6 min (insulin) to 5-7 hours (insulin detemir)